BioSpace News Archive

Business

Broncus Medical (02216.HK) Announces Annual Results for 2021: Operating revenue for 2021 increased 234.2% year-on-year, while product development and commercialization are steadily advancing.

On March 29, 2022, Broncus Medical, the leader in precision interventional treatment for lung diseases in China, announced its annual results announcement for the year ended December 31, 2021.

March 30, 2022
·
5 min read
Business

Dragonfly Therapeutics Expands Clinical Leadership Team, Appointing Dr. Hesham Aboshady as Head of Safety & Pharmacovigilance and Rajesh Israni as Head of Regulatory Affairs

Dragonfly Therapeutics, Inc., announced it has expanded its Clinical Leadership Team with the addition of Dr. Hesham Aboshady, an experienced clinician as Head of Drug Safety, and Rajesh Israni as Head of Regulatory.

March 30, 2022
·
2 min read
U.S. Dental Services Market Witness Growth 6.24% by 2027

The U.S. dental services market size estimated to grow at US$ 196.18 billion by 2027 and is expected to witness growth at a CAGR of 6.24% between 2021 and 2027.

March 30, 2022
·
4 min read
Over the Counter (OTC) Drugs Market Size (US$ 294.18 Bn by 2030) CAGR 6.9%

As per Precedence Research, the over the counter (OTC) drugs market size is estimated to hit US$ 294.18 billion by 2030 and growing at a CAGR of 6.9% from 2021 to 2030.

March 30, 2022
·
4 min read
Pharmaceutical Intermediates Market Size to Worth US$ 47.1 Bn by 2029

The pharmaceutical intermediates market is estimated to worth around US$ 47.1 billion by 2029 and growing at a CAGR of 6.3% from 2021 to 2030.

March 30, 2022
·
4 min read
Oncology Market Size to Worth Around US$ 536.01 BN by 2029

Precedence Research Predicts, the global oncology market size is expected to worth around US$ 536.01 billion by 2029 from valued at USD 286.04 billion in 2021 and growing at a CAGR of 8.2% from 2021 to 2030.

March 30, 2022
·
4 min read
Neurovascular Devices Market Size to Worth Around US$ 4.33 BN by 2029

The global neurovascular devices market size is estimated to worth around US$ 4.33 billion by 2029, poised to grow at a compound annual growth rate (CAGR) of 5.7% during the forecast period 2021 to 2030.

March 30, 2022
·
5 min read
Non-Invasive Aesthetic Treatment Market to Hit US$ 133.87 Bn by 2029

The global non-invasive aesthetic treatment market size is anticipated to hit US$ 133.87 billion by 2029 with a registered CAGR of 12.4% from 2021 to 2030.

March 30, 2022
·
5 min read
Lone Star Bio

Complete Healthcare Management Releases Study on ViiV Healthcare’s Dolutegravir Patent

Today, Complete Healthcare Management Corp. (CHM), released a study on ViiV Healthcare’s U.S. Patent No. 8,129,385 directed to ViiV’s anti-HIV drug, dolutegravir.

March 30, 2022
·
2 min read
Keymed Biosciences Releases 2021 Annual Results

On July 8, 2021, Keymed was listed on the HKEX. During the Reporting Period, the Company continued proceeding the R&D of products and made the following progress with respect to pipeline and business operation:.

March 30, 2022
·
3 min read